Dalbavancin for prosthetic joint infections: Empirical treatment

This publication has 25 references indexed in Scilit:

• Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
  International Journal of Infectious Diseases, 2019
• Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011–2016)
  International Journal of Antimicrobial Agents, 2018
• Dalbavancin in the treatment of different gram-positive infections: a real-life experience
  International Journal of Antimicrobial Agents, 2018
• Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci
  Diagnostic Microbiology and Infectious Disease, 2018
• Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention
  International Orthopaedics, 2015
• Prosthetic Joint Infections
  Surgical Clinics of North America, 2014
• Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model
  International Journal of Antimicrobial Agents, 2013
• Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
  Diagnostic Microbiology and Infectious Disease, 2013
• Early onset prosthetic hip and knee joint infection: treatment and outcomes in Victoria, Australia
  Journal of Hospital Infection, 2012
• Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis)
  Medecine Et Maladies Infectieuses, 2010